Revised SPC: Sandostatin (octreotide) – all presentations

SPC advises that octreotide competitively binds to somatostatin receptors and may interfere with the efficacy of radioactive somatostatin analogues. Administration of octreotide should therefore be avoided 24 hours prior to administration of lutetium (177Lu) oxodotreotide.

Source:

electronic Medicines compendium